Hello Avatar! Welcome back for another week of biotech market analysis. This week we finally got some relief as both the broader and biotech markets have been up. In other exponentially more meaningful news, a major update emerged this morning from the frontlines of the war on cancer. (more detail below)
As a reminder, the purpose of the BowTiedBiotec…
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.